Invasive pituitary adenomas with infrasellar extension can present with epistaxis and nasal obstruction, mimicking nasopharyngeal carcinoma (NPC) and leading to misdiagnosis. A 32‑year‑old male was ...
Vedanta Biosciences is a late clinical-stage biopharmaceutical company developing a new category of microbiome-based oral therapies for gastrointestinal diseases. Vedanta's lead program, VE303, is ...
Clinical practice often begins with empirical therapy, where doctors prescribe antibiotics based on likely causes before lab results confirm the exact organism.
Long before we had modern antibiotics to rely on, people often turned to traditional medicines from plants to treat ...
HYDERABAD: A collaborative study by scientists from CSIR-Centre for Cellular and Molecular Biology and LV Prasad Eye ...
Clearly this week too, the debate surrounding off-patent weight loss drugs has dragged itself into the health limelight. With ...
Researchers from the CSIR-Centre for Cellular and Molecular Biology (CCMB) and the LV Prasad Eye Institute have found alarming levels of antimicrobial resistance (AMR) in bacteria causing eye ...
Long before we had modern antibiotics to rely on, people often turned to traditional medicines from plants to treat ...
Far more than a superficial epithelial problem, corneal melt is a progressive ulceration of corneal stromal tissue that can compromise the structural integrity of the eye. Corneal melt often precedes ...
Acurx Pharmaceuticals, Inc. ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results